When Sales Climb but Profits Tell a Different Story - Dr Lal PathLabs Q4 March 2026 Results
Learning to compare quarterly results both year on year and quarter on quarter helps investors truly understand a company’s financial health and make better informed decisions about their investments.
Every quarter, companies show their report card to the market. Today, Dr Lal PathLabs jumped 15% on NSE. But the real learning is hidden inside the numbers.
Think of it like your exam result. You scored more marks this year than last year — but your percentage dropped. That is exactly what happened here.
• Net Sales grew from ₹602.60 Cr (Mar’25) to ₹702.70 Cr (Mar’26) - up 16.61%
• Net Profit fell from ₹154.80 Cr (Mar’25) to ₹131.30 Cr (Mar’26) - down 15.18%
• Basic EPS dropped from ₹18.57 to ₹7.86
• But vs last quarter (Dec’25), profit jumped from ₹90.50 Cr to ₹131.30 Cr - strong recovery!
The market rewarded sequential improvement. Quarter on quarter profits grew strongly. That gave investors confidence that the business is recovering well.
• Year on Year - compares same quarter of last year
• Quarter on Quarter - compares previous quarter
Both tell different stories. A smart investor reads both.
These are not recommendations - only learning examples.
• Healthcare & Diagnostics sector stocks:
Dr Lal PathLabs LALPATHLAB